Edwards Lifesciences Corporation (EW)
NYSE: EW · IEX Real-Time Price · USD
85.94
-0.51 (-0.59%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Edwards Lifesciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6,005 | 5,382 | 5,233 | 4,386 | 4,348 | 3,723 | 3,435 | 2,964 | 2,494 | 2,323 | Upgrade
|
| Revenue Growth (YoY) | 11.56% | 2.86% | 19.29% | 0.88% | 16.79% | 8.37% | 15.91% | 18.85% | 7.35% | 13.56% | Upgrade
|
| Cost of Revenue | 1,380 | 1,080 | 1,249 | 1,081 | 1,114 | 939.4 | 875.3 | 797.4 | 617.2 | 625.6 | Upgrade
|
| Gross Profit | 4,625 | 4,302 | 3,984 | 3,306 | 3,234 | 2,783 | 2,560 | 2,166 | 1,877 | 1,697 | Upgrade
|
| Selling, General & Admin | 1,825 | 1,568 | 1,494 | 1,228 | 1,242 | 1,089 | 990.8 | 904.7 | 850.7 | 858 | Upgrade
|
| Research & Development | 1,072 | 945.2 | 903.1 | 760.7 | 752.7 | 622.2 | 552.6 | 442.2 | 382.9 | 346.5 | Upgrade
|
| Other Operating Expenses | 220.7 | 76.5 | 20.6 | 405.4 | 91.9 | 330.2 | -12.7 | 67.1 | 7 | -669.7 | Upgrade
|
| Operating Expenses | 3,117 | 2,589 | 2,417 | 2,395 | 2,087 | 2,041 | 1,531 | 1,414 | 1,241 | 534.8 | Upgrade
|
| Operating Income | 1,508 | 1,713 | 1,566 | 911.2 | 1,147 | 742.5 | 1,029 | 752.3 | 635.9 | 1,163 | Upgrade
|
| Interest Expense / Income | 17.6 | 19.2 | 18.4 | 15.8 | 20.7 | 29.9 | 23.2 | 19.2 | 17.2 | 17.2 | Upgrade
|
| Other Expense / Income | -110.8 | -73.9 | -154.2 | -21.3 | -40.4 | -48.8 | -28.8 | -4.8 | -3.7 | 1.3 | Upgrade
|
| Pretax Income | 1,601 | 1,767 | 1,702 | 916.7 | 1,167 | 761.4 | 1,035 | 737.9 | 622.4 | 1,144 | Upgrade
|
| Income Tax | 198.7 | 245.5 | 198.9 | 93.3 | 119.6 | 39.2 | 451.3 | 168.4 | 127.5 | 332.9 | Upgrade
|
| Net Income | 1,402 | 1,522 | 1,503 | 823.4 | 1,047 | 722.2 | 583.6 | 569.5 | 494.9 | 811.1 | Upgrade
|
| Net Income Growth | -7.85% | 1.25% | 82.55% | -21.35% | 44.96% | 23.75% | 2.48% | 15.07% | -38.98% | 108.46% | Upgrade
|
| Shares Outstanding (Basic) | 607 | 619 | 623 | 623 | 625 | 628 | 633 | 639 | 647 | 639 | Upgrade
|
| Shares Outstanding (Diluted) | 609 | 624 | 631 | 632 | 637 | 641 | 648 | 653 | 661 | 651 | Upgrade
|
| Shares Change | -2.37% | -1.11% | -0.11% | -0.75% | -0.66% | -1.05% | -0.87% | -1.13% | 1.52% | -4.66% | Upgrade
|
| EPS (Basic) | 2.31 | 2.46 | 2.41 | 1.32 | 1.68 | 1.15 | 0.92 | 0.89 | 0.77 | 1.27 | Upgrade
|
| EPS (Diluted) | 2.30 | 2.44 | 2.38 | 1.30 | 1.64 | 1.13 | 0.90 | 0.87 | 0.75 | 1.25 | Upgrade
|
| EPS Growth | -5.74% | 2.52% | 83.08% | -20.73% | 45.13% | 25.56% | 3.45% | 16.00% | -39.86% | 118.77% | Upgrade
|
| Free Cash Flow | 642.8 | 973.6 | 1,406 | 647.3 | 928.5 | 688 | 832.6 | 528.3 | 447 | 942.5 | Upgrade
|
| Free Cash Flow Per Share | 1.06 | 1.57 | 2.26 | 1.04 | 1.49 | 1.10 | 1.32 | 0.83 | 0.69 | 1.48 | Upgrade
|
| Gross Margin | 77.02% | 79.93% | 76.13% | 75.36% | 74.37% | 74.77% | 74.52% | 73.09% | 75.25% | 73.07% | Upgrade
|
| Operating Margin | 25.11% | 31.82% | 29.93% | 20.77% | 26.38% | 19.94% | 29.96% | 25.38% | 25.50% | 50.05% | Upgrade
|
| Profit Margin | 23.35% | 28.28% | 28.73% | 18.77% | 24.08% | 19.40% | 16.99% | 19.22% | 19.85% | 34.92% | Upgrade
|
| Free Cash Flow Margin | 10.70% | 18.09% | 26.88% | 14.76% | 21.35% | 18.48% | 24.24% | 17.83% | 17.93% | 40.57% | Upgrade
|
| Effective Tax Rate | 12.41% | 13.89% | 11.69% | 10.18% | 10.25% | 5.15% | 43.61% | 22.82% | 20.49% | 29.10% | Upgrade
|
| EBITDA | 1,792 | 1,953 | 1,884 | 1,068 | 1,302 | 868.7 | 1,140 | 828.3 | 705.4 | 1,230 | Upgrade
|
| EBITDA Margin | 29.84% | 36.29% | 36.00% | 24.35% | 29.94% | 23.33% | 33.18% | 27.95% | 28.29% | 52.94% | Upgrade
|
| Depreciation & Amortization | 173.1 | 166.8 | 163.3 | 135.4 | 114.6 | 77.4 | 81.9 | 71.2 | 65.8 | 68.6 | Upgrade
|
| EBIT | 1,619 | 1,787 | 1,720 | 932.5 | 1,187 | 791.3 | 1,058 | 757.1 | 639.6 | 1,161 | Upgrade
|
| EBIT Margin | 26.96% | 33.19% | 32.88% | 21.26% | 27.30% | 21.26% | 30.80% | 25.55% | 25.65% | 49.99% | Upgrade
|